We provide advanced formulation development services that derive therapeutic innovation. Our expertise includes controlled and sustained release formulations, biologics and biosimilar development, solubility enhancement and 505 (b) (2), hybrid and combination products. Leveraging nanotechnology, advanced drug delivery systems and continuous manufacturing, we create patient-centric solutions to improve medication adherence and efficacy, reduce side effects and ensure regulatory compliance. From drug-device combinations to intellectual property rights support, we deliver tailored formulations that meet market needs and accelerate time-to-market.